Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin (CMR-IMPACT)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT01931852, this NA trial focuses on Acute Coronary Syndrome and Chest Pain and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 20 times since 2013, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
20 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Apr 2022 [monthly]
Completed NA
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
▶ Show 15 earlier versions
-
Nov 2020 — Dec 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2020 — Nov 2020 [monthly]
Active Not Recruiting NA
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting NA
-
Jun 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting NA
-
Mar 2020 — May 2020 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Dec 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
-
Sep 2019 — Dec 2019 [monthly]
Active Not Recruiting NA
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting NA
-
Aug 2018 — Jul 2019 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE3 → NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE3
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .